The follow‐up in patients with pseudoexfoliation of the lens capsule with and without glaucoma

Slagsvold, Jon Erik

doi:10.1111/j.1755-3768.1986.tb06910.x

Cited by 26 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During the period of follow-up in the present study, which averaged approximately three years, four more patients progressed to bilateral exfoliation and five developed glaucoma in eyes with exfoliation. This relatively slow rate of progression has also been noted by others (Slagsvold 1986).…”

Section: Discussionsupporting

confidence: 81%

Exfoliation Syndrome in the Southeastern United States Ii. Characteristics of Patient Population and Clinical Course

1988

Acta Ophthalmologica

View full text Add to dashboard Cite

Fifty-three patients with the exfoliation syndrome, seen at the Duke University Eye Center, Durham, North Carolina, were characterized by a mean age of 71.3 years, a predilection toward women (38 : 15), and a marked preponderance of whites to blacks (51 : 2). There were 31 unilateral and 22 bilateral cases on the initial exam, with glaucoma in 62 of the 75 eyes with exfoliation, as well as 15 of the fellow, non-exfoliation eyes. The incidence of glaucoma is undoubtedly skewed, since the patients were from a glaucoma referral practice. Twenty-four patients were followed from six months to ten years, with a mean of three years, during which time four patients progressed from unilateral to bilateral exfoliation and five more patients acquired glaucoma in eyes with the exfoliation syndrome. The glaucoma associated with the exfoliation syndrome was typically difficult to treat with a high percentage of patients requiring multiple medications or surgical intervention.

show abstract

Section: Discussionsupporting

confidence: 81%

Exfoliation Syndrome in the Southeastern United States Ii. Characteristics of Patient Population and Clinical Course

1988

Acta Ophthalmologica

View full text Add to dashboard Cite

show abstract

“…The changes of glaucoma developing later on in patients with exfoliation are not very high although they nonetheless exist. Concerning the coversion of exfoliation into glaucoma, the difficulty to pick up those patients liable to develop this disease has been discussed (Slagsvold 1984). As a risk group patients with exfoliation need regular follow-up examinations.…”

Section: Discussionmentioning

confidence: 99%

Intraocular Pressure in Exfoliation Syndrome

Klemetti

1988

Acta Ophthalmologica

View full text Add to dashboard Cite

A retrospective follow-up study of 206 eyes with exfoliation in 164 patients was carried out. At the time exfoliation (EX) was initially diagnosed, there were 97 patients with unilateral and 42 patients (84 eyes) with bilateral exfoliation. In 25 patients the exfoliation was connected with hypertension or glaucoma in the fellow eye.The average age of the patients with unilateral EX was 66.3 years and that of the patients with bilateral EX 68.0 years. The initial mean IOP ( k S D ) of 17.9 ( & 2.9) mmHg in 97 unilateral EX eyes was statistically significantly higher (2p < 0.001) than in the normal fellow eye 16.1 (k2.5) mmHg.Of the 97 eyes with unilateral EX, 45.3 Yo with an initial mean IOP of 17.4 mmHg remained unchanged. The mean follow-up time was 5.0 years. Conversion of unilateral to bilateral EX was observed in 14.4 Yo of cases. The mean time of conversion was 4.5 years. Of the 84 bilateral EX eyes with an initial mean IOP of 17.0 mmHg, 66.7 Yo remained unchanged.Of the total sample of 206 EX eyes, 65.5 Yo remained normotensive and 34.5 070 developed hypertension or glaucoma during the follow-up period. The initial mean 1OP of those eyes which remained normotensive was statistically significantly lower than that of those which later on developed hypertension or glaucoma (2p<0.001).

show abstract

“…Twenty percent of open-angle glaucoma worldwide is associated with PXF, and approximately 30% to 50% of patients with PXF develop glaucoma. [48][49][50][51][52][53][54][55][56][57][58] Pseudoexfoliation syndrome is also associated with a higher incidence of narrow angles. [59][60][61][62][63] Chronic angle-closure glaucoma, as well as acute angle-closure glaucoma, can manifest in PXF eyes.…”

Section: Pseudoexfoliation and Intraocular Pressurementioning

confidence: 99%

Pseudoexfoliation and the cataract surgeon: Preoperative, intraoperative, and postoperative issues related to intraocular pressure, cataract, and intraocular lenses

Shingleton¹,

Crandall²,

Ahmed³

2009

Journal of Cataract and Refractive Surgery

149

131

View full text Add to dashboard Cite

This review provides a comprehensive assessment of intraocular pressure (IOP), phacoemulsification techniques, and intraocular lenses (IOLs) in pseudoexfoliation (PXF) eyes having cataract surgery. Pseudoexfoliation is ubiquitous and the most common cause for open-angle glaucoma worldwide. Cataracts occur with increased frequency in PXF eyes, and surgery is potentially complicated by the presence of small pupils and zonule laxity and significantly affects IOP in these eyes. Preoperative evaluation and the options for intraoperative management of cataract are presented with recommendations for the use of adjunctive pupil and zonule support devices. Postoperative complications such as capsule contraction and IOL instability are discussed and laser and surgical options to manage these special problems presented.

show abstract

The follow‐up in patients with pseudoexfoliation of the lens capsule with and without glaucoma

Cited by 26 publications

References 8 publications

Exfoliation Syndrome in the Southeastern United States Ii. Characteristics of Patient Population and Clinical Course

Exfoliation Syndrome in the Southeastern United States Ii. Characteristics of Patient Population and Clinical Course

Intraocular Pressure in Exfoliation Syndrome

Pseudoexfoliation and the cataract surgeon: Preoperative, intraoperative, and postoperative issues related to intraocular pressure, cataract, and intraocular lenses

Contact Info

Product

Resources

About